Literature DB >> 19606163

Nerve fibre layer thinning in patients with preclinical retinopathy.

Pai-Huei Peng1, Huey-Shyan Lin, Shan Lin.   

Abstract

OBJECTIVE: To compare retinal nerve fibre layer thickness (RNFLT) obtained by optical coherence tomography (OCT) between patients with preclinical diabetic retinopathy (DR) and healthy subjects. STUDY
DESIGN: Cross-sectional study. PARTICIPANTS: Ninety-nine type I or II diabetic patients with no visible funduscopic retinal alteration and 77 healthy subjects were included in this study.
METHODS: All participants were evaluated for peripapillary RNFLT by Stratus OCT. In diabetic patients, levels of blood sugar and glycosylated hemoglobin were examined.
RESULTS: The mean RNFLT in diabetic patients and healthy subjects was significantly different (104.2 [SD 10.4] and 108.6 [SD 9.2] microm, respectively; p = 0.004). Compared with the healthy group, the RNFLT in the diabetic group was also significantly less in the superior quadrant and at the 5, 11, and 12 o'clock sectors (p = 0.04, 0.002, and 0.001, respectively). The average RNFLT in diabetic patients with preclinical DR showed a low correlation with fasting blood sugar level (p = 0.03).
CONCLUSIONS: The mean and superior quadrant peripapillary RNFLT was slightly less in diabetic patients without abnormal vascular manifestations than in healthy subjects. Furthermore, lower RNFLT values in patients with preclinical DR appears to be weakly associated with high levels of fasting blood sugar.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19606163     DOI: 10.3129/i09-112

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  27 in total

1.  Evaluation of optic disc, retinal nerve fiber and macular ganglion cell layers in pediatric diabetes.

Authors:  Evre Pekel; Selda Ayça Altıncık; Gökhan Pekel
Journal:  Int Ophthalmol       Date:  2017-08-05       Impact factor: 2.031

2.  Reduced levels of brain derived neurotrophic factor (BDNF) in the serum of diabetic retinopathy patients and in the retina of diabetic rats.

Authors:  M Shamsul Ola; Mohd Imtiaz Nawaz; Ahmed Abu El-Asrar; Marwan Abouammoh; Abdullah S Alhomida
Journal:  Cell Mol Neurobiol       Date:  2012-12-28       Impact factor: 5.046

Review 3.  Presence and Risk Factors for Glaucoma in Patients with Diabetes.

Authors:  Brian J Song; Lloyd Paul Aiello; Louis R Pasquale
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

4.  Evaluation of retinal nerve fiber layer thickness profile in thyroid ophthalmopathy without optic nerve dysfunction.

Authors:  Kumari Mugdha; Apjit Kaur; Neha Sinha; Sandeep Saxena
Journal:  Int J Ophthalmol       Date:  2016-11-18       Impact factor: 1.779

5.  Diabetic Retinopathy-Update on Prevention Techniques, Present Therapies, and New Leads.

Authors:  Lauren M Marozas; Patrice E Fort
Journal:  US Ophthalmic Rev       Date:  2014

6.  Glucose variability and inner retinal sensory neuropathy in persons with type 1 diabetes mellitus.

Authors:  M S Stem; G E Dunbar; G R Jackson; S Farsiu; R Pop-Busui; T W Gardner
Journal:  Eye (Lond)       Date:  2016-04-01       Impact factor: 3.775

Review 7.  Neurodegeneration as a primary change and role of neuroprotection in diabetic retinopathy.

Authors:  Vishal Jindal
Journal:  Mol Neurobiol       Date:  2014-05-15       Impact factor: 5.590

8.  Early retinal neurodegeneration in preclinical diabetic retinopathy: a multifactorial investigation.

Authors:  Ibrahim Toprak; Semin Melahat Fenkci; Guzin Fidan Yaylali; Cigdem Martin; Volkan Yaylali
Journal:  Eye (Lond)       Date:  2019-10-25       Impact factor: 3.775

9.  A Real-World Single-Centre Study of Patients with Diabetic Macular Oedema Who Wore a Home-Use Sleep Mask (Noctura 400) for One Year.

Authors:  Ulrich Meyer-Bothling; Oliver Meyer-Bothling; Marika Pinney
Journal:  J Ophthalmol       Date:  2021-06-15       Impact factor: 1.909

10.  Neurodegeneration and neuroprotection in diabetic retinopathy.

Authors:  Mohammad Shamsul Ola; Mohd Imtiaz Nawaz; Haseeb A Khan; Abdullah S Alhomida
Journal:  Int J Mol Sci       Date:  2013-01-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.